December 19, 2024 - 10:12

Hosts Madison Mills and Brad Smith dive into the latest market developments in today's episode. The Federal Reserve is set to announce its interest rate decision later this afternoon, a move that could significantly impact the financial landscape. Fed Reporter Jennifer Schonberger provides an analysis of current Wall Street expectations, while Frances Donald, chief economist at RBC Global, shares insights on why a Federal Reserve easing cycle may not be the best course of action in the current economic climate.
In addition to the Fed's decision, Baird Investment strategist Ross Mayfield raises concerns about market concentration, particularly regarding the so-called "Magnificent Seven" stocks, suggesting that fears surrounding this issue may be exaggerated. Furthermore, Yahoo Finance correspondent Ben Werschkul discusses President Biden's recent remarks on stock trading restrictions for lawmakers, adding another layer to the ongoing conversation about market regulation.
Today's episode also highlights several trending tickers, including Honda, Tesla, Boeing, Birkenstock, and General Mills, offering listeners a comprehensive overview of the current market situation.
March 15, 2026 - 03:23
Audit finds strong oversight at Fort Worth Housing Finance Corp, flags minor control gapsA recent operational audit of the Fort Worth Housing Finance Corporation has concluded that the agency maintains strong overall oversight, though it identified a handful of minor internal control...
March 14, 2026 - 07:39
Nvidia GTC, Macy's earnings, FOMC meeting: What to WatchThe upcoming week presents a critical lineup of events for the financial markets, with major corporate developments and a key Federal Reserve meeting on the calendar. All eyes will be on the...
March 13, 2026 - 20:57
Richard Donoff Encourages Americans to Prioritize Long-Term Financial PreparednessIn a recent address, financial expert Richard Donoff emphasized the critical need for American families to shift their focus toward long-term financial preparedness. He advocates for a proactive...
March 13, 2026 - 04:55
Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate UpdateCapricor Therapeutics has announced its financial results for the fourth quarter and full year 2025, alongside significant progress in its lead clinical program. The company`s Biologics License...